Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Novus Therapeutics Inc. (NVUS)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
OrbiMed Advisors

Samuel Isaly

2,537,110 $10,199 0.15%
2. 201,906 $812 -14% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$3.10 646,204 Large Shareholder, Director 3,183,314 2019-05-02 Filing
$3.10 646,204 Director 3,183,314 2019-05-02 Filing
$5.02 16,632 Officer 78,199 2018-09-12 Filing
$4.56 17,048 Officer 61,567 2018-09-11 Filing
$3.97 805 Officer 805 2018-09-05 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$1.91 1,914 88,662 2019-05-21 Filing
$1.96 7,623 90,576 2019-05-20 Filing
$1.91 1,058 5,974 2019-05-21 Filing
$1.96 4,218 7,032 2019-05-20 Filing
$1.91 2,937 156,918 2019-05-21 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 324,383 $1,304 0.15%
2. 159,705 $643 0.08%
3. 10,000 $40 0.03%
4. 12,189 $49 0%
5. 4,747 $19 0%
News See All